Posts

Posted on

Maxeon Solar Technologies Announces Initiative to Expand Engagement in U.S. Solar Power Market

– New Performance Panel Supply Chain Planned for Increased Focus on U.S. Sales –

PR Newswire

SINGAPORE, April 6, 2021 /PRNewswire/ — Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN), a global leader in solar innovation and channels, today announced a major new initiative to expand its engagement in the rapidly growing U.S. solar power market. The Company plans to increase its focus on selling its Performance line shingled module technology in the U.S., facilitated by the deployment of up to 3.6 GW of new shingled module assembly capacity in two phases. The expansion is contingent upon the Company obtaining debt or equity financing to purchase the equipment, after which initial sales are expected to start in the first quarter of 2022.

“We are excited to announce this initiative to expand our presence in the U.S. market. By leveraging existing supply chain assets in North America, we can offer Maxeon’s industry-leading shingled module technology to the rapidly growing U.S. market,” said Jeff Waters, CEO of Maxeon Solar Technologies. “Maxeon already has a strong presence in the U.S. rooftop Distributed Generation (“DG”) market through our supply of Interdigitated Back Contact (IBC) panels to SunPower Corporation. We expect to expand the scope of this partnership by also supplying Performance panels to SunPower for use in its DG business, broadening their offering to capture more of the available market. We intend to also complement and expand our U.S. presence with direct sales into the large and rapidly growing large-scale segment, which is not addressed by our current SunPower partnership.”

“Maxeon and SunPower have agreed to an option to expand their exclusive DG supply agreement to cover a multi-year commitment for Performance line solar panels in addition to IBC products”, commented Norm Taffe, SunPower Corporation EVP. “We are eager to expand our product portfolio by adding Maxeon’s Performance line shingled panels to our premium IBC line. Based on Maxeon’s sales experience outside the U.S., we believe that this complete product portfolio will enable us to expand our share of account through our channel and penetrate new markets with a solar panel made at substantial scale in North America.”

Maxeon plans to implement its new Performance line capacity in two phases. In phase one, Maxeon plans to use existing facilities to quickly ramp 1.8 GW of new capacity. Large-format G12 mono-PERC solar cells are planned to be manufactured in the Company’s manufacturing site in Malaysia, and module assembly is planned to be performed at Maxeon’s facility in Mexicali, Mexico. In parallel, Maxeon will conduct a comprehensive process to select an optimal site for a U.S. based module assembly facility with a capacity of up to an additional 1.8 GW. Depending on site conditions and market demand, this second phase is expected to begin operation in 2023. 

Waters continued: “By using existing manufacturing facilities for phase one, we can leverage our current plant footprint and our experienced, highly trained work force to quickly ramp volume of our advanced Performance line solar panels for sale into the U.S. market. Greater volume in Malaysia and Mexico will also enhance overhead utilization, helping to drive down cost for our industry-leading IBC products. Our Mexicali factory offers a particularly efficient outbound logistics profile for customers in the Southwest U.S. region. This and later planned expansion of our Performance line module assembly capacity in the U.S. will bring our supply chain even closer to our customers.”

The new capacity will be used to manufacture Maxeon’s latest shingled bifacial panel technology, with rated power of up to 650 watts per panel and efficiency of over 21%. While Maxeon’s primary target market for the new capacity will be utility-scale power plants and large commercial and industrial systems, the Company also plans to produce panels suitable for DG applications in the residential and light commercial segments.

About Maxeon Solar Technologies
Maxeon Solar Technologies (NASDAQ:MAXN) is Powering Positive Change™. Headquartered in Singapore, Maxeon designs, manufactures and sells SunPower® brand solar panels in more than 100 countries, operating the SunPower brand worldwide except the United States and Canada. The company is a leader in solar innovation with access to over 1,000 patents and two best-in-class solar panel product lines. With operations in Africa, Asia, Oceania, Europe and Mexico, Maxeon products span the global rooftop and solar power plant markets through a network of more than 1,100 trusted partners and distributors. A pioneer in sustainable solar manufacturing, Maxeon leverages a 35-year history in the solar industry and numerous awards for its technology. For more information about how Maxeon is Powering Positive Change™ visit us at www.maxeon.com, on LinkedIn and on Twitter @maxeonsolar.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the timing and the company’s expectations of success in its expansion strategy in existing and in new markets; the Company’s liquidity, substantial indebtedness, and ability to obtain additional financing for our projects; and the Company’s expectations regarding projected growth, profitability and cost savings from planned operational and supply chain improvements. These forward-looking statements are based on our current assumptions, expectations and beliefs and involve substantial risks and uncertainties that may cause results, performance or achievement to materially differ from those expressed or implied by these forward-looking statements.  A detailed discussion of these factors and other risks that affect our business is included in filings we make with the Securities and Exchange Commission (“SEC”) from time to time, including our most recent report on Form 20-F, particularly under the heading “Item 3.D. Risk Factors.” Copies of these filings are available online from the SEC or on the Financials & Filings section of our Investor Relations website at www.maxeon.com/financials-filings/sec-filings. All forward-looking statements in this press release are based on information currently available to us, and we assume no obligation to update these forward-looking statements in light of new information or future events.

© 2021 Maxeon Solar Technologies, Ltd. All Rights Reserved. MAXEON is a registered trademark of Maxeon Solar Technologies, Ltd. Visit

www.maxeon.com/trademarks

 for more information.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/maxeon-solar-technologies-announces-initiative-to-expand-engagement-in-us-solar-power-market-301263424.html

SOURCE Maxeon Solar Technologies, Ltd.

Posted on

Organon Announces Proposed Senior Notes Offering

Organon Announces Proposed Senior Notes Offering

KENILWORTH, N.J.–(BUSINESS WIRE)–
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that Organon Finance 1 LLC plans to offer, subject to market conditions, euro-denominated senior secured notes due 2028, U.S. dollar-denominated senior secured notes due 2028 and U.S. dollar-denominated senior unsecured notes due 2031 (collectively, the “notes”), in connection with the previously announced spinoff of Organon & Co. (“Organon”) from Merck. As part of the spinoff, the notes will be assumed by Organon and a Dutch private limited company and wholly owned subsidiary of Organon which will act as co-issuer of the notes.

Organon intends to use the net proceeds from the notes offering, together with available cash on its balance sheet and borrowings under senior secured credit facilities which Organon anticipates entering into, to repay one or more intercompany loans or notes owed by Organon to a Merck affiliate and to pay fees and expenses related to the spinoff. The proceeds of the notes offering will be held in escrow until satisfaction of the conditions precedent to the spinoff and certain other escrow release conditions.

The notes have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), any state securities laws or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration or an applicable exemption from registration. Accordingly, the notes are being offered and sold only to persons reasonably believed to be qualified institutional buyers in accordance with Rule 144A under the Securities Act and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act.

This announcement is an advertisement and is not a prospectus for the purposes of Regulation (EU) 2017/1129 (as amended, the “Prospectus Regulation”) or Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the “UK Prospectus Regulation”).

In member states of the European Economic Area, this announcement is directed only at persons who are “qualified investors” within the meaning of the Prospectus Regulation. In the United Kingdom, this announcement is directed only at persons who are “qualified investors” within the meaning of the UK Prospectus Regulation.

Manufacturer target market (MiFID II product governance / UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document has been prepared as not available to retail in the EEA. No UK PRIIPs key information document has been prepared as not available to retail in the UK.

In the United Kingdom, this announcement is directed only at persons (i) that have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the “Order”); (ii) falling within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations etc.”) of the Order; or (iii) at whom this announcement may otherwise be directed without contravention of Section 21 of the Financial Services and Markets Act 2000, as amended (all such persons together being referred to as “relevant persons”). This announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

This press release does not constitute an offer to sell, or the solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Organon

Organon will be a global healthcare company formed through a spinoff from Merck to focus on improving the health of women throughout their lives. It will have a portfolio of more than 60 trusted medicines that address an entire spectrum of conditions women face. Led by the growing reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products producestrong cash flows that will support investments in future growth opportunities in women’s health. In addition, Organon will pursue opportunities to partner with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast-growing international markets.

Organon is expected to have a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, N.J.

About Merck

For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases – as we aspire to be the premier research-intensive biopharmaceutical company in the world.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Examples of forward-looking statements include statements with respect to the company’s plans to spinoff certain of its businesses into an independent company, the timing and structure of such spinoff, the characteristics of the business to be separated, the expected benefits of the spinoff to the company and the expected effect on the company’s dividends. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to whether the proposed spinoff will be completed on the proposed timetable or at all. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, uncertainties as to the timing of the proposed spinoff; uncertainties as to the status of any required regulatory approvals; the possibility that various conditions to the consummation of the spinoff may not be satisfied; the effects of disruption from the transactions contemplated in connection with the spinoff; general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; the impact of the global outbreak of novel coronavirus disease (COVID-19); global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

Media:

Patrick Ryan

(973) 275-7075

Jessica Fine

(908) 608-4859

Investors:

Peter Dannenbaum

(908) 740-1037

Raychel Kruper

(908) 740-2107

KEYWORDS: United States North America New Jersey

INDUSTRY KEYWORDS: Biotechnology Health Pharmaceutical Clinical Trials Oncology

MEDIA:

Logo
Logo
Posted on

Northern Oil and Gas, Inc. Announces Closing of Reliance Marcellus Acquisition

Northern Oil and Gas, Inc. Announces Closing of Reliance Marcellus Acquisition

MINNEAPOLIS–(BUSINESS WIRE)–
Northern Oil and Gas, Inc. (NYSE American: NOG) (“Northern”) announced today that it closed on its previously announced acquisition of properties owned by Reliance Marcellus, LLC on April 1, 2021.

HIGHLIGHTS

  • Extends Northern’s non-operated model to Appalachia – the leading US natural gas basin – and creates a national non-operated franchise, diversified by region and commodity mix
  • Northern paid closing consideration of $120.9 million in cash (including previously paid deposit), which is subject to final post-closing settlement, and 3.25 million common stock warrants
  • The cash closing payment was funded with borrowings under Northern’s revolving credit facility, which had $263.0 million of outstanding borrowings as of March 31, 2021, prior to funding the closing, a reduction of $24.0 million from the previously announced balance as of March 11, 2021
  • 2021 guidance reiterated for the acquired assets, including production of 75-85 MMcfpd and $20-25MM of CAPEX
  • Northern has hedged approximately 66% of forecasted remaining 2021 PDP gas production on the acquired assets at an average price of $3.00/MMbtu and 36% of forecasted Q1:2022 PDP gas production at an average price of $3.17/MMbtu

MANAGEMENT COMMENTS

“We are pleased to have closed this transformational acquisition, which enhances our high-return national non-operated business model with a key move into the Marcellus,” commented Nick O’Grady, Northern’s Chief Executive Officer. “Furthermore, this transaction and our recent balance sheet advancements have positioned Northern as the natural consolidator of non-operated assets. With the Board and Management’s substantial ownership of Northern’s equity, we will only entertain transactions that clearly add immediate shareholder value and are accretive to our free cash flow and future dividend potential.”

ABOUT NORTHERN OIL AND GAS

Northern Oil and Gas, Inc. is a company with a primary strategy of investing in non-operated minority working and mineral interests in oil & gas properties, with a core area of focus in the premier basins within the United States. More information about Northern Oil and Gas, Inc. can be found at www.NorthernOil.com.

SAFE HARBOR

This press release contains forward-looking statements regarding future events and future results that are subject to the safe harbors created under the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical facts included in this release regarding Northern’s financial position, business strategy, plans and objectives of management for future operations and industry conditions are forward-looking statements. When used in this press release, forward-looking statements are generally accompanied by terms or phrases such as “estimate,” “project,” “predict,” “believe,” “expect,” “continue,” “anticipate,” “target,” “could,” “plan,” “intend,” “seek,” “goal,” “will,” “should,” “may” or other words and similar expressions that convey the uncertainty of future events or outcomes. Items contemplating or making assumptions about actual or potential future production and sales, market size, collaborations, and trends or operating results also constitute such forward-looking statements.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond Northern’s control) that could cause actual results to differ materially from those set forth in the forward looking statements, including the following: changes in crude oil and natural gas prices; the pace of drilling and completions activity on Northern’s properties and properties pending acquisition; Northern’s ability to acquire additional development opportunities; potential or pending acquisition transactions; changes in Northern’s reserves estimates or the value thereof; disruptions to Northern’s business due to acquisitions and other significant transactions; general economic or industry conditions, nationally and/or in the communities in which Northern conducts business; changes in the interest rate environment, legislation or regulatory requirements; conditions of the securities markets; Northern’s ability to raise or access capital; changes in accounting principles, policies or guidelines; financial or political instability, acts of war or terrorism, and other economic, competitive, governmental, regulatory and technical factors affecting Northern’s operations, products and prices; and the COVID-19 pandemic and its related economic repercussions and effect on the oil and natural gas industry. Additional information concerning potential factors that could affect future financial results is included in the section entitled “Item 1A. Risk Factors” and other sections of Northern’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as updated from time to time in amendments and subsequent reports filed with the SEC, which describe factors that could cause Northern’s actual results to differ from those set forth in the forward looking statements. Northern has based these forward-looking statements on its current expectations and assumptions about future events. While management considers these expectations and assumptions to be reasonable, they are inherently subject to significant business, economic, competitive, regulatory and other risks, contingencies and uncertainties, most of which are difficult to predict and many of which are beyond Northern’s control. Northern does not undertake any duty to update or revise any forward-looking statements, except as may be required by the federal securities laws.

Mike Kelly, CFA

Chief Strategy Officer

(952) 476-9800

[email protected]

KEYWORDS: Minnesota United States North America

INDUSTRY KEYWORDS: Oil/Gas Energy

MEDIA:

Logo
Logo
Posted on

Equity Commonwealth Announces First Quarter 2021 Earnings Conference Call

Equity Commonwealth Announces First Quarter 2021 Earnings Conference Call

CHICAGO–(BUSINESS WIRE)–
Equity Commonwealth (NYSE: EQC) announced today that the company will release its first quarter 2021 operating results on Tuesday, May 4, 2021, after market close. A conference call to discuss those results will be held on Wednesday, May 5, 2021, at 9:00 am Central Time. The conference call will be available via live audio webcast on the Investor Relations section of the company’s website (www.eqcre.com). A replay of the audio webcast will also be available following the call.

About Equity Commonwealth

Equity Commonwealth (NYSE: EQC) is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties in the United States. EQC’s same property portfolio is comprised of 4 properties and 1.5 million square feet.

Regulation FD Disclosures

We use any of the following to comply with our disclosure obligations under Regulation FD: press releases, SEC filings, public conference calls, or our website. We routinely post important information on our website at www.eqcre.com, including information that may be deemed to be material. We encourage investors and others interested in the company to monitor these distribution channels for material disclosures.

Sarah Byrnes, Equity Commonwealth, (312) 646-2801

KEYWORDS: United States North America Illinois

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo
Posted on

Herbalife Nutrition Ltd. Announces First Quarter 2021 Earnings Release Date and Investor Call

Herbalife Nutrition Ltd. Announces First Quarter 2021 Earnings Release Date and Investor Call

LOS ANGELES–(BUSINESS WIRE)–
Global nutrition company, Herbalife Nutrition Ltd. (NYSE:HLF) will release its first quarter 2021 financial results after the close of trading on the NYSE on Tuesday, May 4, 2021. The same day, at 5:30 p.m. ET (2:30 p.m. PT), the Herbalife Nutrition senior management team will host an investor conference call to discuss its recent financial results and provide an update on current business trends.

The dial-in number for this conference call for domestic callers is (833) 962-1459, and (956) 394-3596 for international callers (Conference ID 3526984). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company’s website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID: 3526984). The webcast of the teleconference will be archived and available on Herbalife Nutrition’s website.

About Herbalife Nutrition Ltd.

Herbalife Nutrition is a global company that has been changing people’s lives with great nutrition products and a proven business opportunity for its independent distributors since 1980. The Company offers high-quality, science-backed products, sold in over 90 countries by entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle. Through the Company’s global campaign to eradicate hunger, Herbalife Nutrition is also committed to bringing nutrition and education to communities around the world.

Media Contact:

Jennifer Butler

VP, Media Relations

213.745.0420

Investor Contact:

Eric Monroe

Senior Director, Investor Relations

213.745.0449

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Other Retail Health Marketing Specialty Communications Food/Beverage Fitness & Nutrition Retail

MEDIA:

Logo
Logo
Posted on

Phreesia Announces Proposed Public Offering of Common Stock

Phreesia Announces Proposed Public Offering of Common Stock

RALEIGH, N.C.–(BUSINESS WIRE)–
Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the actual size and terms of the offering.

J.P. Morgan and William Blair are acting as joint book-running managers for the Offering and as representatives of the underwriters. Allen & Company LLC and Piper Sandler are acting as passive book-running managers for the Offering.

The Offering will be made only by means of a prospectus supplement and an accompanying prospectus. When available, copies of the preliminary prospectus supplement and accompanying prospectus relating to the Offering may be obtained from: J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, telephone: 1-866-803-9204; or from William Blair & Company, L.L.C., Attention: Prospectus Department, 150 North Riverside Plaza, Chicago, IL 60606, telephone: 1-800-621-0687.

An automatic shelf registration statement on Form S-3ASR relating to these securities is on file with the Securities and Exchange Commission (the “SEC”) and is effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT PHREESIA

Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients in their healthcare and provides a modern, consistent experience, while enabling healthcare organizations to enhance clinical care and drive efficiency.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This press release includes express or implied statements that are not historical facts and are considered forward-looking statements within the meaning of Section 27A of the Securities Act, as amended, and Section 21E of the Securities Exchange Act, as amended, including, without limitation, statements concerning our expectations regarding the consummation of the Offering and the terms of the Offering. Forward-looking statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance and may contain projections of our future results of operations or of our financial information or state other forward-looking information. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future operational or financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control. The forward-looking statements contained in this release are also subject to other risks and uncertainties, including, without limitation, market risks and uncertainties and the satisfaction of customary closing conditions relating to the Offering, and other risks and uncertainties more fully described in our filings with the SEC, including in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021 that has been filed with the SEC and in the “Risk Factors” section of the preliminary prospectus supplement related to the Offering. The forward-looking statements in this press release speak only as of the date on which the statements are made. We undertake no obligation to update, and expressly disclaim the obligation to update, any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.

Forward-looking statements speak only as of the date hereof, and, except as required by law, Phreesia undertakes no obligation to update or revise these forward-looking statements.

Phreesia qualifies all of its forward-looking statements by these cautionary statements.

Investors:

Balaji Gandhi

Phreesia, Inc.

[email protected]

(929) 506-4950

Media:

Maureen McKinney

Phreesia, Inc.

[email protected]

(773) 330-8908

KEYWORDS: United States North America North Carolina

INDUSTRY KEYWORDS: Technology Hospitals Software Practice Management Networks Managed Care Health General Health Data Management

MEDIA:

Logo
Logo
Posted on

Telos Corporation Completes Follow-On Offering

ASHBURN, Va., April 06, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (“Telos”) (Nasdaq: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, announced today the closing of its follow-on offering (the “Offering”) of 9,090,909 shares of common stock at a price of $33.00 per share, including a secondary public offering of 7,040,909 shares of common stock by certain existing stockholders of Telos (the “Selling Stockholders”). The Offering included a full exercise of the underwriters’ option to purchase additional shares of common stock at the offering price, less underwriting discounts and commissions, to cover over-allotments. After giving effect to the full exercise of the option, the gross proceeds to Telos increased to $64,605,750. Telos did not receive any proceeds from the shares of common stock sold by the Selling Stockholders.

B. Riley Securities, BMO Capital Markets, and Needham & Company acted as joint bookrunners for the offering. D.A. Davidson & Co., Wedbush Securities, Colliers Securities LLC, Northland Capital Markets, and MKM Partners served as co-managers for the Offering.

The shares of common stock described above were offered by Telos and the Selling Stockholders pursuant to a “shelf” registration statement that was filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2021, which was automatically effective upon filing, and a final prospectus supplement.

The Offering has been made only by means of a prospectus. Copies of the final prospectus relating to this Offering may be obtained from: B. Riley Securities, Inc., Attn: Prospectus Department, 1300 North 17th Street, Suite 1300, Arlington, VA 22209, telephone: (703) 312-9580, or by emailing [email protected]; BMO Capital Markets Corp., Attn: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036, telephone: (800) 414-3627, or by emailing [email protected]; or Needham & Company, LLC, Attn: Prospectus Department, 250 Park Avenue, 10th Floor, New York, NY 10177, telephone: (800) 903-3268, or by emailing [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Offering. There can be no assurance that Telos will be able to complete the proposed offering of additional shares on the anticipated terms, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Telos, including risks and uncertainties related to the satisfaction of customary closing conditions related to the offering of additional shares and those set forth in the Risk Factors section of Telos’ registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. Telos undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

About Telos Corporation


Telos Corporation
 (NASDAQ: TLS) empowers and protects the world’s most security-conscious organizations with solutions for continuous security assurance of individuals, systems, and information. Telos’ offerings include cybersecurity solutions for IT risk management and information security; cloud security solutions to protect cloud-based assets and enable continuous compliance with industry and government security standards; and enterprise security solutions for identity and access management, secure mobility, organizational messaging, and network management and defense. The company serves military, intelligence and civilian agencies of the federal government, allied nations and commercial organizations around the world.

Media:

Mia Wilcox
Merritt Group on behalf of Telos Corporation
Email: [email protected]         
Phone: (610) 564-6773

Investors:

Brinlea Johnson
The Blueshirt Group on behalf of Telos Corporation
[email protected]



Posted on

Cincinnati Financial Schedules Webcast to Discuss First-Quarter 2021 Results

PR Newswire

CINCINNATI, April 6, 2021 /PRNewswire/ — Cincinnati Financial Corporation (Nasdaq: CINF) invites you to listen to the live internet broadcast of its conference call to discuss first-quarter 2021 results on Thursday, April 29, 2021, at 11 a.m. ET. The company plans to release its results on Wednesday, April 28, after the close of regular trading on the Nasdaq Stock Market.


What:          

CINF first-quarter 2021 earnings conference call


When:         

Thursday, April 29, 2021, at 11 a.m. ET


Where:        

Live over the internet.


How:           

Visit www.cinfin.com/investors. Participants are encouraged to go to the website to test your systems for compatibility prior to the time of the call.


Replay:       

A replay of the call will be available at cinfin.com/investors beginning approximately two hours after the completion of the live call.


Contact:     

Stephanie Johnson, 513-870-2768

About the Company: Cincinnati Financial Corporation offers primarily business, home and auto insurance through The Cincinnati Insurance Company and its two standard market property casualty companies. The same local independent insurance agencies that market those policies may offer products of our other subsidiaries, including life insurance, fixed annuities and surplus lines property and casualty insurance. For additional information about the company, please visit cinfin.com.

Also available on the company’s website will be information reconciling any non–GAAP financial measures to be discussed on the conference call.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cincinnati-financial-schedules-webcast-to-discuss-first-quarter-2021-results-301263451.html

SOURCE Cincinnati Financial Corporation

Posted on

Trulieve Brings Medical Cannabis to Dunedin

PR Newswire

The location marks the first dispensary in Dunedin, broadening access to the state’s largest inventory of medical cannabis

TALLAHASSEE, Fla., April 6, 2021 /PRNewswire/ – Trulieve Cannabis Corp. (CSE: TRUL) (OTC: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, announced today the opening of a brand-new Florida dispensary, the Company’s 84th nationwide.

The dispensary furthers Trulieve’s goal of ensuring direct, reliable access to medical cannabis across its home state of Florida. The company’s 79th Florida dispensary joins nearby locations in Tampa, St. Petersburg, and Tarpon Springs and brings direct, in-store access to registered patients in Dunedin for the first time.

In honor of the Company’s brand-new dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new dispensary on opening day.

ANNOUNCING: Trulieve Dunedin Grand Opening 
WHERE: 1846 Main Street, Dunedin, FL 34698
WHEN: Thursday, April 8, 2021, at 9:00 a.m.

In stores and online, patients will find Florida’s largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 79 dispensaries in Florida.

To assist patients with ordering, Trulieve has made the entire catalog of products available for online ordering, with in-store pickup and statewide home delivery options available. Patients can schedule a complimentary 30-minute virtual consultation with a Trulieve certified consultant to help navigate questions on products, devices, or review their doctor’s recommendation.

All visitors are required to wear masks for the duration of their dispensary visit. Only patients and their state-approved caregivers will be allowed inside the waiting room and dispensary at this time.

To assist with CDC recommendations for social distancing and in compliance with additional company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients. These include modifications to the layout of all stores, installation of plexiglass partitions and HEPA air filtration scrubbers in every dispensary, increasing access to masks and sanitizer throughout the store for staff and visitors, utilizing visual aids to direct traffic throughout the store, and increasing the frequency of deep cleanings for all dispensaries.

Trulieve is closely monitoring the coronavirus situation and will update store policies as needed to ensure the highest level of safety of our patients and staff. All updates will be shared directly on Trulieve’s website as they are enacted.

The Office of Medical Marijuana Use recently announced the registry has surpassed 520,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state’s overall volume per the Florida Department of Health. To support the state’s rapidly growing patient base, there are over 2,500 registered ordering physicians in the State of Florida.

For more information, please visit www.Trulieve.com.

About Trulieve 
Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida. Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded stores (dispensaries) throughout the State of Florida, as well as directly to patients via home delivery. Trulieve also has operations in California, Massachusetts, Connecticut and Pennsylvania. Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF.

To learn more about Trulieve, visit www.Trulieve.com.

Cision View original content:http://www.prnewswire.com/news-releases/trulieve-brings-medical-cannabis-to-dunedin-301263472.html

SOURCE Trulieve Cannabis Corp.

Posted on

MoneyGram Announces Hilary Jackson as New Chief Operating Officer

Ms. Jackson’s strong track record in technology, innovation, and operations at customer-centric financial services companies will be a significant asset in the next stage of the Company’s digital transformation

PR Newswire

DALLAS, April 6, 2021 /PRNewswire/ — MoneyGram International, Inc. (NASDAQ: MGI), a global leader in cross-border P2P payments and money transfers, today announced the appointment of Hilary Jackson as its new Chief Operating Officer reporting to Alex Holmes, Chairman and CEO. The appointment is effective April 26, 2021.

Ms. Jackson joins MoneyGram from Selene Holdings where she served as Chief Operating Officer. Prior to joining Selene, Ms. Jackson held multiple executive roles at Capital One, including Head of Technology for Top of House Products within Capital One’s Financial Services division, and Head of Home Loans Servicing.  

Hilary also spent 12 years at Bank of America, where she provided executive leadership in the mortgage lines of business. Within mortgage servicing, she led risk assessment and analytics, horizontal business controls, business transformation, strategic implementation, program management, and loss mitigation operations. She also held executive leadership roles within the mortgage originations and sales organizations. 

“We are thrilled to welcome Hilary Jackson as our new Chief Operating Officer,” said Alex Holmes, MoneyGram Chairman and CEO. “As we continue to accelerate our digital transformation, Hilary’s strong track record of success leading technology and operations functions in the financial services sector will be critical to helping MoneyGram continue to lead the evolution of digital P2P payments and mobilize the movement of money.”

About MoneyGram International, Inc.

MoneyGram is leading the evolution of digital P2P payments. With a purpose-driven strategy to mobilize the movement of money, a strong culture of fintech innovation, and leading customer-centric capabilities, MoneyGram has grown to serve nearly 150 million people across the globe over the last five years.

The Company leverages its modern, mobile, and API-driven platform and collaborates with the world’s leading brands to serve consumers through MoneyGram Online (MGO), its direct-to-consumer digital business, its global retail network and its emerging embedded finance business for enterprise customers, MoneyGram as a Service.

For more information, please visit ir.moneygram.com and follow @MoneyGram.

Media Contact

Stephen Reiff

[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/moneygram-announces-hilary-jackson-as-new-chief-operating-officer-301263390.html

SOURCE MoneyGram